Full-Time
Vancouver, Remote
Salary: $90,000-110,000


ABOUT THE ROLE

This role is a full-time position based remotely within Canada, though office space is available in Vancouver or Victoria, BC. The role offers a base salary of $90,000-110,000 and a comprehensive employment benefits package.

The Lead Investigator’s primary responsibilities will include, but not be limited to, the following:

  • Leading the development and implementation of the Diabetes Reduction Bond’s impact measurement and evaluation strategy by:
    • Working with the Impact Measurement Team to develop community-based process, outcome, and impact evaluation plans
    • Training community-based impact measurement assistants
    • Collaborating with the Social Finance Analyst to incorporate Indigenous impact metrics into the Bond model
  • Working in collaboration the Project Manager by:
    • Engaging in relationship management, particularly with community partners
    • Supporting annual reporting
    • Compiling reader-friendly materials about the Bond’s impact and evaluation plans for project partners

 

KEY ATTRIBUTES WE ARE SEEKING

  • Ability to build relationships and maintain trust
  • Demonstrated desire to support the well-being of Indigenous Peoples
  • Highly motivated self-starter
  • Strong analytical and research skills
  • A high degree of accuracy with strong attention to detail

 

QUALIFICATIONS

  • PhD in the health or medicine, ideally in diabetes
  • Extensive experience in community-based research
  • Minimum 3-5 years’ experience working in, or with, Indigenous organizations or communities
  • High proficiency in designing ethical, OCAP-compliant research/outcomes measurement
  • Deep familiarity with community-based participatory research methods
  • Advanced presentation and communications skills
  • A strong work ethic

HOW TO APPLY

Interested candidates are invited to submit a resume and cover letter to:  Info@riif.ca 

Attention:  Paul Lacerte, Director of Impact

Indigenous women and non-binary candidates will be given preference. s16(1) CHRA.